QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $1.11 billion. The enterprise value is $3.85 billion.
| Market Cap | 1.11B |
| Enterprise Value | 3.85B |
Important Dates
The next confirmed earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 68.19 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Current Share Class | 68.19M |
| Shares Outstanding | 68.19M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 119.35% |
| Float | 62.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.73 |
| PS Ratio | 0.42 |
| Forward PS | 0.41 |
| PB Ratio | 0.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 168.62 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.55.
| Current Ratio | 1.43 |
| Quick Ratio | 0.65 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.26 |
Financial Efficiency
Return on equity (ROE) is -49.95% and return on invested capital (ROIC) is 1.08%.
| Return on Equity (ROE) | -49.95% |
| Return on Assets (ROA) | 0.51% |
| Return on Invested Capital (ROIC) | 1.08% |
| Return on Capital Employed (ROCE) | -17.67% |
| Weighted Average Cost of Capital (WACC) | 6.09% |
| Revenue Per Employee | $408,800 |
| Profits Per Employee | -$186,292 |
| Employee Count | 6,500 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, QuidelOrtho has paid $32.50 million in taxes.
| Income Tax | 32.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.08% in the last 52 weeks. The beta is 0.69, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -31.08% |
| 50-Day Moving Average | 15.64 |
| 200-Day Moving Average | 20.65 |
| Relative Strength Index (RSI) | 47.71 |
| Average Volume (20 Days) | 1,165,740 |
Short Selling Information
The latest short interest is 11.80 million, so 17.31% of the outstanding shares have been sold short.
| Short Interest | 11.80M |
| Short Previous Month | 11.51M |
| Short % of Shares Out | 17.31% |
| Short % of Float | 19.00% |
| Short Ratio (days to cover) | 6.97 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.66 billion and -$1.21 billion in losses. Loss per share was -$17.81.
| Revenue | 2.66B |
| Gross Profit | 1.20B |
| Operating Income | 49.50M |
| Pretax Income | -1.18B |
| Net Income | -1.21B |
| EBITDA | -487.20M |
| EBIT | -824.70M |
| Loss Per Share | -$17.81 |
Balance Sheet
The company has $140.40 million in cash and $2.87 billion in debt, with a net cash position of -$2.73 billion or -$40.10 per share.
| Cash & Cash Equivalents | 140.40M |
| Total Debt | 2.87B |
| Net Cash | -2.73B |
| Net Cash Per Share | -$40.10 |
| Equity (Book Value) | 1.85B |
| Book Value Per Share | 27.19 |
| Working Capital | 414.60M |
Cash Flow
In the last 12 months, operating cash flow was $6.60 million and capital expenditures -$166.00 million, giving a free cash flow of -$159.40 million.
| Operating Cash Flow | 6.60M |
| Capital Expenditures | -166.00M |
| Depreciation & Amortization | 442.20M |
| Net Borrowing | 176.00M |
| Free Cash Flow | -159.40M |
| FCF Per Share | -$2.34 |
Margins
Gross margin is 45.18%, with operating and profit margins of 1.86% and -45.57%.
| Gross Margin | 45.18% |
| Operating Margin | 1.86% |
| Pretax Margin | -44.35% |
| Profit Margin | -45.57% |
| EBITDA Margin | -18.22% |
| EBIT Margin | -30.84% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
| Earnings Yield | -108.81% |
| FCF Yield | -14.32% |
Analyst Forecast
The average price target for QuidelOrtho is $21.33, which is 30.70% higher than the current price. The consensus rating is "Hold".
| Price Target | $21.33 |
| Price Target Difference | 30.70% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 1.99% |
| EPS Growth Forecast (3Y) | 9.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 0.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.61 |
| Piotroski F-Score | 5 |